Survival Benefit of Zoledronic Acid in Postmenopausal Breast Cancer Patients Receiving Aromatase Inhibitors

PURPOSE: A growing body of evidence indicates that zoledronic acid (ZA) can improve the clinical outcome in patients with breast cancer and low estrogen levels. In the present study, we aimed to investigate the survival benefit of ZA administration in postmenopausal Korean women with breast cancer w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Sung Gwe, Kim, Sung Hyun, Lee, Hak Min, Lee, Seung Ah, Jeong, Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278054/
https://www.ncbi.nlm.nih.gov/pubmed/25548583
http://dx.doi.org/10.4048/jbc.2014.17.4.350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278054/
https://www.ncbi.nlm.nih.gov/pubmed/25548583
http://dx.doi.org/10.4048/jbc.2014.17.4.350

Ejemplares similares